News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,752 Results
Type
Article (85285)
Company Profile (625)
Press Release (738842)
Section
Business (231887)
Career Advice (4091)
Deals (39623)
Drug Delivery (106)
Drug Development (90449)
Employer Resources (192)
FDA (17898)
Job Trends (17246)
News (394693)
Policy (39586)
Tag
Academia (2973)
Africa (1263)
Alliances (56346)
Alzheimer's disease (1250)
Approvals (17807)
Arizona (210)
Artificial intelligence (86)
Asia (49021)
Australia (8619)
Bankruptcy (392)
Best Places to Work (12270)
Biotechnology (438)
C2C Services and Suppliers (95111)
California (2071)
Canada (960)
Cancer (563)
Career advice (3498)
Cell therapy (145)
China (162)
Clinical research (70487)
Collaboration (162)
Colorado (88)
Compensation (88)
Connecticut (86)
COVID-19 (2757)
Cystic fibrosis (78)
Data (342)
Diabetes (92)
Diagnostics (6505)
Drug pricing (86)
Earnings (93540)
Employer resources (162)
Europe (112082)
Events (125051)
Executive appointments (169)
FDA (18145)
Florida (280)
Funding (159)
Gene therapy (110)
GLP-1 (623)
Government (5011)
Healthcare (20657)
Hotbed/Location (534575)
Illinois (325)
Indiana (164)
Infectious disease (2791)
Inflammatory bowel disease (103)
Interviews (804)
IPO (17499)
Job creations (5172)
Job search strategy (2850)
Kansas (100)
Layoffs (468)
Legal (10014)
Lung cancer (130)
Manufacturing (106)
Maryland (442)
Massachusetts (1746)
Medical device (14272)
Medtech (14277)
Mergers & acquisitions (21972)
Metabolic disorders (304)
Michigan (139)
Minnesota (236)
Neuroscience (1426)
New Jersey (630)
New York (637)
NextGen Class of 2024 (7622)
Non-profit (5054)
North Carolina (706)
Northern California (861)
Obesity (181)
Ohio (113)
Opinion (234)
Patents (83)
Pennsylvania (603)
People (63743)
Pharmaceutical (119)
Phase I (21640)
Phase II (30602)
Phase III (23125)
Pipeline (116)
Podcasts (76)
Postmarket research (3532)
Preclinical (9775)
Radiopharmaceuticals (251)
Rare diseases (143)
Real estate (7363)
Recruiting (72)
Regulatory (25622)
Research institute (2633)
Resumes & cover letters (645)
South America (1641)
Southern California (795)
Startups (4273)
Texas (272)
United States (9543)
Vaccines (574)
Washington State (284)
Weight loss (173)
Date
Today (43)
Last 7 days (587)
Last 30 days (2486)
Last 365 days (39800)
2024 (28415)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,752 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Almirall to Present New Data on Biologics for Psoriasis and Atopic Dermatitis and Celebrates 80 Years of Innovation at the EADV Congress
September 23, 2024
·
11 min read
Press Releases
European Commission Approves LEO Pharma’s Anzupgo® (delgocitinib) Cream for Adults with Moderate to Severe Chronic Hand Eczema (CHE)
September 23, 2024
·
9 min read
Press Releases
FDA Accepts LEO Pharma’s Filing of Delgocitinib Cream New Drug Application for the Treatment of Chronic Hand Eczema
September 23, 2024
·
10 min read
Press Releases
Sharps Technology, Inc. Announces $3.5 Million Bridge Financing
September 23, 2024
·
4 min read
Press Releases
Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)
September 23, 2024
·
4 min read
Press Releases
IDEAYA Biosciences Announces Positive Interim Phase 2 Data for Darovasertib and Successful FDA Type C Meeting on Registrational Trial Design for Regulatory Approval in Neoadjuvant Uveal Melanoma
September 23, 2024
·
10 min read
Press Releases
Kodiak Sciences to Host Investor R&D Day Today at 10:30am Eastern Time
September 23, 2024
·
1 min read
Press Releases
Italian Studies Confirm Safety of HOPE (Hypothermic Oxygenated PErfusion) for Liver Transplantation and Value of HOPE in Identifying Biomarkers for Assessing Liver Viability
September 23, 2024
·
5 min read
Press Releases
Impressive preliminary objective response rates (ORR) of 36% in NSCLC and 80% in EGFRmut NSCLC: Interim Results of a Phase 1 Study of BC3195, a First-in-Class ADC Targeting CDH3, Presented by BioCity at ESMO 2024
September 23, 2024
·
4 min read
Press Releases
XOMA Royalty Declares Quarterly Preferred Stock Dividends
September 23, 2024
·
2 min read
1 of 82,476
Next